Vergoeding 2018-2022 voor ATC-subgroep J05AG : Niet-nucleoside reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| J05AG01 Nevirapine (Viramune ®) | 2.800.700 | 1.756.900 | 1.508.600 | 1.066.100 | 869.850 |
| J05AG03 Efavirenz (Stocrin ®) | 514.910 | 424.690 | 370.120 | 349.750 | 222.110 |
| J05AG04 Etravirine (Intelence ®) | 720.070 | 598.070 | 498.550 | 427.590 | 395.040 |
| J05AG05 Rilpivirine (Rekambys ®) | 313.950 | 295.320 | 270.420 | 392.020 | 1.170.300 |
| J05AG06 Doravirine (Pifeltro ®) | . | 14.082 | 272.610 | 510.480 | 751.960 |
| Totaal | 4.349.630 | 3.089.062 | 2.920.300 | 2.745.940 | 3.409.260 |